A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
- Conditions
- Arthritis, Psoriatic
- Interventions
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 91
- Registration Number
- NCT05071664
- Locations
- ๐ต๐ฑ
WroMedica I Bielicka A Strzalkowska s c, Wroclaw, Poland
๐บ๐ธArizona Arthritis and Rheumatology Research PLLC, Phoenix, Arizona, United States
๐บ๐ธUnity Health-White County Medical Center, Searcy, Arkansas, United States
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 166
- Registration Number
- NCT05050097
- Locations
- ๐บ๐ธ
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
๐บ๐ธIndiana University, Indianapolis, Indiana, United States
๐บ๐ธTennessee Oncology, Nashville, Tennessee, United States
A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 182
- Registration Number
- NCT05029921
- Locations
- ๐จ๐ณ
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China
๐จ๐ณPeking University Third Hospital, Beijing, China
๐จ๐ณThe Military General Hospital of Beijing PLA, Beijing, China
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
- Conditions
- Prostatic Neoplasms
- Interventions
- Drug: Bridging Therapy
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT05022849
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States
๐บ๐ธLevine Cancer Institute, Charlotte, North Carolina, United States
๐บ๐ธCity of Hope Cancer Center, Duarte, California, United States
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 42
- Registration Number
- NCT05014360
- Locations
- ๐บ๐ธ
University of Miami, Miami, Florida, United States
๐บ๐ธCity of Hope, Duarte, California, United States
๐ซ๐ทHopital Edouard Herriot - CHU Lyon, Lyon, France
A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of Interest
- Conditions
- Healthy
- Interventions
- Radiation: UVB Challenge
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT05007756
- Locations
- ๐ง๐ช
Clinical Pharmacology Unit, Merksem, Belgium
A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 1
- Registration Number
- NCT05005507
- Locations
- ๐บ๐ธ
I.D. Care, Inc., Hillsborough, New Jersey, United States
๐ช๐ธHosp. Univ. Vall D Hebron, Barcelona, Spain
๐ช๐ธHosp. Univ. Infanta Leonor, Madrid, Spain
A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 53
- Registration Number
- NCT04991753
- Locations
- ๐ต๐ฑ
Prywatna Praktyka Lekarska Prof Um Dr Hab Med Pawel Hrycaj, Poznan, Poland
๐บ๐ธArizona Arthritis & Rheumatology Associates PC, Glendale, Arizona, United States
๐บ๐ธArizona Arthritis & Rheumatology Research, PLLC, Tucson, Arizona, United States
A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 39
- Registration Number
- NCT04991740
- Locations
- ๐ฎ๐ฑ
Rambam Medical Center, Haifa, Israel
๐ช๐ธHosp. Univ. Vall D Hebron, Barcelona, Spain
๐ฎ๐ฑSourasky Medical Center, Tel Aviv, Israel
A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 6
- Registration Number
- NCT04990440
- Locations
- ๐ฆ๐ท
Conexa Investigacion Clinica S.A., Caba, Argentina
๐ฆ๐ทClรญnica Adventista Belgrano, Caba, Argentina
๐ฆ๐ทCINME - Centro de Investigaciones Metabolicas, Ciudad de Buenos Aires, Argentina